Stock Information

• Caris Life Sciences Highlights Growing Urgency Of Closing Geographic Gap In Cancer Clinical Trial Access And Role Of RIT Clinical Trial Solution Plays In Bringing Biomarker-Driven Trials To Community Oncology Practices Nationwide
  Wed, Apr 15, 2026 8:39 AM
• Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
  Wed, Apr 15, 2026 8:32 AM
• Caris Life Sciences shares are trading higher after Jefferies initiated its coverage on the stock with a Buy rating and announced a price target of $28.
  Mon, Apr 13, 2026 2:42 PM
• Leggett & Platt, Allogene Therapeutics, Revolution Medicines And Other Big Stocks Moving Higher On Monday
  Mon, Apr 13, 2026 10:29 AM
• Caris Life Sciences: Post-IPO Pullback Creates A Long-Term Buy Opportunity
  Mon, Apr 13, 2026 8:30 AM
• Jefferies Initiates Coverage On Caris Life Sciences with Buy Rating, Announces Price Target of $28
  Mon, Apr 13, 2026 8:24 AM

Financial data not available